Table 2.
Deviation of SGRQ (ΔSGRQ) subscores from expected values in pSS patients with COPD (pSS+COPD) vs. pSS patients without COPD (pSS–COPD) as well as in pSS patients with ILD (pSS+ILD) vs. pSS patients without ILD (pSS–ILD)
| pSS+COPD (n = 21) | pSS–COPD (n = 30) | p value | |
|---|---|---|---|
| ΔSGRQ symptoms score | 24.4 (6.5; 41.6) | 21.3 (1.2; 36.7) | 0.39 |
| ΔSGRQ activity score | 18.8 (6.3; 47.3) | 21.8 (0.8; 35.6) | 0.85 |
| ΔSGRQ impact score | 10.6 (0.1; 23.8) | 6.6 (−0.7; 22.0) | 0.42 |
| ΔSGRQ total score | 23.0 (2.5; 31.5) | 18.5 (1.2; 27.4) | 0.48 |
| pSS+ILD (n = 9) | pSS–ILD (n = 42) | p value | |
|---|---|---|---|
| ΔSGRQ symptoms score | 33.6 (0.3; 49.1) | 22.3 (3.1; 36.7) | 0.54 |
| ΔSGRQ activity score | 34.7 (8.7; 50.3) | 15.4 (−2.6; 38.7) | 0.24 |
| ΔSGRQ impact score | 12.0 (1.2; 22.9) | 7.9 (−0.6; 23.0) | 0.60 |
| ΔSGRQ total score | 27.4 (5.3; 31.6) | 14.4 (1.9; 27.6) | 0.26 |
Results are presented as deviation in points from expected values [median (IQR)]